BIG
ORIC icon

Brooklyn Investment Group’s Oric Pharmaceuticals ORIC Stock Holding History

Brooklyn Investment Group’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-17,082
Closed -$176K – 1545
2025
Q3 		$176K Sell
17,082
-3,821
-18% -$40.2K 0.02% 608
2025
Q2 		$212K Buy
+20,903
New +$140K 0.03% 584
2025
Q1 		– Sell
-105
Closed -$848 – 2857
2024
Q4 		$848 Buy
+105
New +$963 ﹤0.01% 1636

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $74.1B AUM 71.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Brooklyn Investment Group's ORIC Position: Q4 2025 in Review

Brooklyn Investment Group sold out of Oric Pharmaceuticals (ORIC) in Q4 2025, closing a stake of 17,082 shares — an estimated $176K sold.

Brooklyn Investment Group first reported a position in ORIC in Q4 2024 and held it in 3 quarters. The position peaked at $212K in Q2 2025. 164 funds tracked by Wall St. Rank hold ORIC as of Q4 2025.

  • Brooklyn Investment Group reported no remaining Oric Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Brooklyn Investment Group sold 17,082 Oric Pharmaceuticals shares in Q4 2025, an estimated $176K.
  • Brooklyn Investment Group first reported a position in Oric Pharmaceuticals in Q4 2024 and held it in 3 quarters.
  • Brooklyn Investment Group's Oric Pharmaceuticals position peaked at $212K in Q2 2025.
  • 164 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q4 2025.

Based on Brooklyn Investment Group's 13F filing for Q4 2025, filed 12 Feb 2026.